Funder: National Institutes of Health
Due Dates: June 10, 2025 | December 9, 2025 | June 10, 2026 | December 9, 2026
Funding Amounts: Phase I: up to $306,872 (6 months) | Phase II: up to $2,045,816 (2 years); higher caps possible for select topics; see NOFO for details.
Summary: Supports U.S. small businesses developing products, processes, or services to improve minority health and eliminate health disparities.
Key Information: Only U.S. small businesses are eligible; clinical trials are optional; strict SBIR eligibility and foreign disclosure rules apply.